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Abstract
Depression of left ventricular (LV) intrinsic contractility is constant in patients with septic shock. Because most
parameters of cardiac function are strongly dependent on afterload, especially in this context, the cardiac
performance evaluated at the bedside reflects intrinsic contractility, but also the degree of vasoplegia. Recent
advances in echocardiography have allowed better characterization of septic cardiomyopathy. It is always reversible
providing the patient’s recovery. Unlike classic cardiomyopathy, it is not associated with high filling pressures, for
two reasons: improvement in LV compliance and associated right ventricular dysfunction. Although, it is unclear to
which extent it affects prognosis, a hyperkinetic state is indicative of a profound and persistent vasoplegia
associated with a high mortality rate. Preliminary data suggest that the hemodynamic response to a dobutamine
challenge has a prognostic value, but large studies are required to establish whether inotropic drugs should be
used to treat this septic cardiac dysfunction.
Introduction
Reversible myocardial depression in patients with septic
shock was first described in 1984 by Parker et al. using
radionuclide cineangiography [1]. In a series of 20
patients, they reported a 65% incidence of left ventricu-
lar (LV) systolic dysfunction, defined by an ejection frac-
tion <45% [1]. In 1990, using transthoracic
echocardiography, Jardin et al. reported the same results
[2]. In a canine model simulating human septic shock,
Natanson et al. demonstrated that intrinsic LV perfor-
mance was actually depressed in all animals and not
corrected by volume expansion [3]. Finally, more
recently, Barraud et al. confirmed the presence of severe
depressed intrinsic LV contractility using LV pressure/
volume loops in lipopolysaccharide-treated rabbits [4].
All of these studies, and many others not cited in this
introduction, demonstrate the reality of the impairment
of intrinsic LV contractility in septic shock. For many
years, septic cardiac dysfunction was largely underesti-
mated because the hemodynamic device used, i.e., the
pulmonary artery catheter, was not appropriate for
establishing such a diagnosis. Development of new
hemodynamic tools at the bedside, such as echocardio-
graphy, allowed better characterization of the septic car-
diomyopathy [5]. The following review explains the
mechanisms of such a depression, its characteristics,
incidence, and finally its impact on treatment and prog-
nosis. We decided not to deal with the place and the
role of biomarkers, which will be presented in a future
review of the journal.
Mechanisms
Many factors may contribute to cardiac depression dur-
ing sepsis. Studies performed in humans have ruled out
coronary hypoperfusion requiring coronary intervention
as a cause of LV systolic dysfunction in sepsis [6,7]. Of
course, patients with coronary disease may behave
differently.
On the other hand, the role of cytokines has been
strongly advocated in the genesis of septic cardiomyopa-
thy. In 1985, Parrillo et al. demonstrated in vitro that
myocardial cell shortening is reduced by exposure to the
serum of septic patients [8]. Later, the same team
showed that the circulating factor responsible for this
was tumor necrosis factor a (TNF-a) [9,10], even
though later studies have implicated other cytokines,
such as interleukin-1b [11]. Kumar et al. suggested that
the effect of cytokines on cardiac myocytes results from
an increase in intracellular cGMP and in nitric oxide
[12]. In addition, direct alteration in cellular respiration
with mitochondrial dysfunction also was advocated [13],
and, finally, Tavernier et al. suggested that increased
phosphorylation of troponin I was involved by reducing
myofilament response to Ca2+ [14].
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The first characteristic of septic cardiomyopathy is that
it is acute and reversible, providing the patient recovers.
In 90 patients during a 5-year period, Jardin et al.
reported that LV ejection fraction is normalized in a few
days [15], as also reported more recently by Bouhemad
et al. [16].
The second characteristic, which is crucial to full
understanding, is that depressed LV systolic function is
associated with normal or low LV filling pressure, unlike
the “classic” pattern of cardiogenic shock where LV
pressures are elevated (Figure 1). This may explain why
the pulmonary artery catheter has for many years under-
estimated the incidence of LV systolic dysfunction. Jar-
d i ne ta l .a n dB o u h e m a de ta l .r e p o r t e da na v e r a g e
pulmonary capillary wedge pressure close to 11 mmHg
in patients with decreased LV ejection fraction, which is
not significantly different from that found in patients
with a preserved ejection fraction [2,16]. In the study by
Parker et al., the pulmonary capillary wedge pressure
was 14 mmHg on average in patients with LV ejection
fraction <45% [1].
Two mechanisms may explain this absence of elevated
LV pressures. The first relates to the frequent associa-
tion with right ventricular (RV) dysfunction. Vincent et
al. in a group of 93 patients with septic shock reported
a decreased RV ejection fraction compared with a “con-
trol” group [17]. Similar results were found by Kimchi
et al. and Parker et al. [18,19]. Using transesophageal
echocardiography, we reported that almost 30% of
patients have RV dilatation, which is highly suggestive
of significant RV dysfunction (Figure 2) [20]. RV dys-
function is related to acute pulmonary hypertension,
which is frequently associated in this situation because
Figure 1 Transesophageal echocardiography in two patients–one with cardiogenic shock (above) and the other with septic shock
(below). In the patient with cardiogenic shock, the left ventricular short-axis view demonstrated global hypokinesia of the left ventricle with
major dilatation. Pulsed Doppler at the mitral valve demonstrated a restrictive pattern of the left ventricular inflow with a high E wave velocity
and a very low A wave velocity, highly suggestive of a high LV filling pressure. Note also the thrombus in the left ventricle (arrow). In the patient
with septic shock, the short-axis view also demonstrated global hypokinesia of the left ventricle, but without a major dilatation. Note also the
Doppler profile at the mitral valve, highly suggestive of normal LV filling pressure.
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lity due to circulating cytokines [18]. It protects the pul-
monary circulation [21] and avoids significant elevation
of LV pressures.
The second mechanism relates to LV compliance
alteration, which usually occurs. In their original work,
Parker et al. suggested a huge increase in LV compli-
ance; they found a dilatation of the left ventricle of
more than 100% [1]. This very impressive LV “preload
adaptation” was actually never confirmed and was prob-
ably explained in part by technical errors related to the
use of the pulmonary artery catheter. Most studies using
echocardiography only report a slight increase in LV
size in patients with decreased LV ejection fraction
compared with patients with preserved ejection fraction,
suggesting a true but slight increase in LV compliance
in these patients (Table 1) [16,20,22]. In 12 normal
healthy volunteers, Suffredini et al. demonstrated that
injection of endotoxin induces a depression of LV systo-
lic function associated with a significant decrease in the
ratio of pulmonary capillary wedge pressure to LV end-
d i a s t o l i cv o l u m ei n d e x[ 2 3 ] . A limited but significant
increase in LV end-diastolic volume (+15%) was
reported after volume loading with a pulmonary capil-
lary wedge pressure less augmented than in the control
group [23].
Incidence
The reported incidence of LV systolic dysfunction varies
significantly (Table 2). This is easy to understand,
because the LV afterload plays a crucial role in the eva-
luation of cardiac function. As well illustrated by Robot-
h a me ta l .[ 2 4 ] ,t h es a m ev a l u eo fL Ve j e c t i o nf r a c t i o n
may correspond to very different levels of intrinsic LV
contractility: for instance, an ejection fraction of 60%
may correspond to a severe impairment of LV contracti-
lity, if the afterload is very low, as it is in septic shock
before resuscitation. As shown by all animal studies, we
must consider that the presence of depressed LV intrin-
sic performance is constant in septic shock. Accordingly,
LV ejection fraction actually reflects the LV afterload
rather than the intrinsic contractility. During the 6 first
hours of resuscitation, we found an 18% incidence of a
hypokinetic profile, associating low cardiac index and
decreased LV ejection fraction [20]. In another study,
where echocardiography was performed later, we
reported a 40% incidence of LV systolic dysfunction
Figure 2 Long-axis view of the left ventricle by a transesophageal approach in a patient ventilated for septic shock. At day 1 (panel A),
the patient had right ventricular dysfunction illustrated by major dilatation of the right ventricle. At day 2 (panel B), this was corrected. RV, right
ventricle; LV, left ventricle.
Table 1 End-diastolic size of the left ventricle according
to the ejection fraction
LV end-diastolic size
Decreased LVEF Preserved LVEF
Parker et al. [1]
20 patients, PAC
LVEDV 159 ± 29 mL/m
2 81 ± 9 mL/m
2 *
Jardin et al. [2]
21 patients, TTE
LVEDV 76 ± 18 mL/m
2 70 ± 20 mL/m
2
Jardin et al. [15]
90 patients, TTE
LVEDV 80 ± 21 mL/m
2 62 ± 15 mL/m
2 *
Vieillard-Baron et al. [25]
67 patients, TEE
LVEDV 76 ± 24 mL/m
2 68 ± 24 mL/m
2
Bouhemad et al. [16]
45 patients, TEE
LVEDA 13 ± 3 cm
2/m
2 11 ± 2 cm
2/m
2 *
PAC, pulmonary artery catheter; TTE, transthoracic echocardiography; TEE,
transesophageal echocardiography; LVEF, left ventricular ejection fraction;
LVEDV, left ventricular end-diastolic volume; LVEDA, left ventricular end-
diastolic area.
*p < 0.05.
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the incidence increased to 60% after 2 and 3 days [25],
probably because of the restoration of a normal LV
afterload by norepinephrine or by the natural evolution
of the infectious process. This is why echocardiography,
when repeated at different times, may show how norepi-
nephrine infusion may unmask poor intrinsic LV
contractility (Figure 3). Interestingly, in the study by Jar-
din et al., the systemic vascular resistances were signifi-
cantly lower in patients with a preserved LV ejection
fraction than in patients with decreased ejection fraction
[2]. A similar result was reported by Parker et al. [1]. In
our study, 15% of patients after 6 hours had a hyperki-
netic profile, associating tachycardia, supra-normal LV
Table 2 Incidence of LV systolic dysfunction in septic shock according to the time of evaluation
Time of study/admission Incidence of LV systolic dysfunction
Parker et al. [1]
PAC + radionuclide cineangiography
Day 1 65%
Jardin et al. [2]
TTE
0-6 hours 29%
Vieillard-Baron et al. [20]
TEE
0-6 hours 18%
Vieillard-Baron et al. [25]
TEE
Day 1, 2, 3 60%
Bouhemad et al. [16]
TEE
? 20%
Etchecopar-Chevreuil et al. [22]
TEE
12 hours 46%
PAC, pulmonary artery catheter; TTE, transthoracic echocardiography; TEE, transesophageal echocardiography.
Figure 3 Short-axis view of the left ventricle by a transgastric approach in a patient with septic shock at baseline after initial
resuscitation and after a few hours of norepinephrine infusion. Note that restoration of a “normal” left ventricular afterload has unmasked
impaired contractility. LVEF, left ventricular ejection fraction.
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volume expansion, and high cardiac index–a pattern
reflecting persistent and veryp r o f o u n dv a s o p l e g i a[ 2 0 ] .
In 2003, we reported a series of 183 patients with septic
shock who were all monitored hemodynamically by
using echocardiography through transthoracic or transe-
sophageal route [5]. As shown in Figure 4, the relation-
ship between LV ejection fraction and cardiac index
may be separated into four parts, depending on LV
afterload, volemia, and RV function.
Prognosis and treatment
It is very difficult to establish whether septic cardiomyopa-
thy independently affects the prognosis of patients with
septic shock, because many other variables are involved,
such as age, patient history, type of microorganisms, and
time to resuscitation. Initially, Parker et al. suggested that
development of septic cardiomyopathy was “protective”
[1]. Ten of the 13 survivors had an LV ejection fraction
<40%, but none of the nonsurvivors [1]. In appearance, we
found different results with a mortality rate of 43% in
patients with a hypokinetic profile compared with 24% in
patients with a normokinetic profile [20]. We also found
that patients with a hyperkinetic profile (small left ventri-
cle, supranormal ejection fraction, tachycardia, high car-
diac index) had a 100% mortality rate [20]. Actually, rather
than a “protective” effect of LV systolic dysfunction, we
can conclude that the prognosis is poor in the presence of
a hyperkinetic state, which reflects persistent and pro-
found vasoplegia, as explained above. Table 3 summarizes
the main studies and their results in terms of survival and
LV systolic function.
Figure 4 Relationship between left ventricular (LV) ejection fraction (x axis) and cardiac index (y axis) in 183 patients with septic
shock who underwent echocardiography. Providing that depressed LV intrinsic contractility is constant, the relation may be separated into
four parts according to systemic vascular resistance, volemia, and right ventricular (RV) function. Size of the circles is related to LV end-diastolic
volume, from 35 for the smallest to 135 ml for the biggest.
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The first is volume expansion. Parker et al. suggested
that “massive” fluid infusion maintains a normal cardiac
index, despite a significantly impaired LV contractility,
through LV preload adaptation [1]. However, we have
learned that this dilatation is limited and that fluid over-
load is deleterious for survival [26,27]. In the study by
Ognibene et al., volume infusion was unable to restore
normal left ventricular function and unmasked a flat
Frank-Starling curve in the 21 patients with septic shock
[28]. In our study, LV stroke index and LV end-diastolic
volume did not correlate, whereas LV stroke index and
LV ejection fraction were strongly correlated [20].
Nevertheless, volume expansion must always be pro-
posed first to restore central blood volume in the case
of absolute or relative hypovolemia.
The second therapeutic option is the infusion of an
inotropic drug, such as dobutamine, a beta-agonist
agent. We and others reserve this treatment for patients
with persistent shock, lactic acidosis, and oliguria
[25,29]. In this situation, dobutamine increases LV ejec-
tion fraction and cardiac index [25,29]. To which extent
such a treatment may improve the patient’s prognosis is
unknown. However, it is well established that the cardi-
ovascular response to dobutamine stress predicts out-
come in sepsis. Vallet et al. using a dose of 10 μg/kg per
min and Rhodes et al. using a dose of 5 μg/kg per min
reported that patients with an increased oxygen con-
sumption (>15%) in response to dobutamine infusion
have a much higher survival rate [30,31]. This was
related to a significant increase in cardiac index and
oxygen delivery [30,31]. More recently, Kumar et al. per-
formed a “dobutamine challenge” at 5, 10, and 15 μg/kg
per min in 23 patients with septic shock [32]. They also
found that survival was associated with increased cardiac
performance and LV contractility indices [32]. In parti-
cular, a cutoff value of 8.5 mL/m
2 increase in LV stroke
index in response to dobutamine correctly categorized
the outcome in 21 of 23 patients [32]. Levosimendan, a
new calcium sensitizer, also has been proposed to treat
septic cardiomyopathy. It may improve not only LV but
also RV function in the context of sepsis [33,34]. Bar-
r a u de ta l .i na ne n d o t o x i nm o d e li nr a b b i t sr e p o r t e d
that LV systolic elastance was restored during levosi-
mendan infusion [4].
Finally, a few words should be mentioned about nore-
pinephrine administration. As explained above and
shown in Figure 3, norepinephrine infusion may unmask
the impairment of LV contractility. However, some
authors recently have suggested that administration of
norepinephrine for restoring mean arterial pressure in
the early phase of septic shock also increased cardiac
output through an increase in both cardiac preload and
cardiac contractility [35]. Such findings remain to be
confirmed.
Conclusions
Depression of LV intrinsic contractility is constant in
patients with septic shock. Because most parameters of
cardiac function are strongly dependent on afterload,
especially in this context, cardiac performance evaluated
at the bedside reflects intrinsic contractility but also the
degree of vasoplegia. Recent advances in echocardiogra-
phy have allowed better characterization of septic cardi-
omyopathy. Unlike classic cardiomyopathy, it is not
associated with high filling pressures for two reasons:
increased LV compliance and frequently associated RV
dysfunction. It is always reversible. Although it is
unclear how septic cardiomyopathy affects outcome, a
hyperkinetic state is indicative of profound and persis-
tent vasoplegia associated with a high mortality rate.
Preliminary data suggest that the hemodynamic
response to dobutamine challenge has a prognostic
value, but large studies are required to establish whether
inotropic drugs should be used to treat this septic car-
diac dysfunction.
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